Oral OTEZLA® receives negative NICE recommendation for adults with chronic plaque psoriasis

Celgene working with NICE to ensure OTEZLA is made available to patients in England and Wales as soon as possible

Source: Pharmacy Europe - September 30, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Rheumatology Patient care Research apremilast FAD ICER Latest News nice OTEZLA PDE4 psoriasis Source Type: news